Amgen To Present At The Cowen 4th Annual IO Summit Read more about Amgen To Present At The Cowen 4th Annual IO Summit
Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma Read more about Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma
Amgen Showcases New Data Across Cardiovascular Portfolio At AHA Scientific Sessions 2020: A Virtual Experience Read more about Amgen Showcases New Data Across Cardiovascular Portfolio At AHA Scientific Sessions 2020: A Virtual Experience
Amgen Presents First Clinical Data for AMG 757 at SITC 2020 Read more about Amgen Presents First Clinical Data for AMG 757 at SITC 2020
Amgen To Present At The 29th Annual Credit Suisse Healthcare Conference Read more about Amgen To Present At The 29th Annual Credit Suisse Healthcare Conference
Amgen Reports Third Quarter 2020 Financial Results Read more about Amgen Reports Third Quarter 2020 Financial Results
Amgen Announces Webcast Of 2020 Third Quarter Financial Results Read more about Amgen Announces Webcast Of 2020 Third Quarter Financial Results
Global Coalition for Adaptive Research, Amgen, and Eisai Announce First Patient Enrolled in International COVID-19 Trial Read more about Global Coalition for Adaptive Research, Amgen, and Eisai Announce First Patient Enrolled in International COVID-19 Trial
Amgen Announces Participation Of Systemic Lupus Erythematosus (SLE) Adaptive Clinical Trial In The FDA Complex Innovative Trial Designs (CID) Pilot Program Read more about Amgen Announces Participation Of Systemic Lupus Erythematosus (SLE) Adaptive Clinical Trial In The FDA Complex Innovative Trial Designs (CID) Pilot Program
Amgen Announces 2020 Fourth Quarter Dividend Read more about Amgen Announces 2020 Fourth Quarter Dividend
